Comparison of two established approaches for generating Hounsfield look-up tables for CT-based SPR prediction.
1/5 보강
[BACKGROUND] To ensure consistency in treatment planning across institutions, inter-center variations in Hounsfield look-up tables (HLUTs) have been evaluated using different methods in Japan and Euro
APA
Nakao M, Schwengfelder J, et al. (2026). Comparison of two established approaches for generating Hounsfield look-up tables for CT-based SPR prediction.. Medical physics, 53(1), e70236. https://doi.org/10.1002/mp.70236
MLA
Nakao M, et al.. "Comparison of two established approaches for generating Hounsfield look-up tables for CT-based SPR prediction.." Medical physics, vol. 53, no. 1, 2026, pp. e70236.
PMID
41423715 ↗
DOI
10.1002/mp.70236
Abstract 한글 요약
[BACKGROUND] To ensure consistency in treatment planning across institutions, inter-center variations in Hounsfield look-up tables (HLUTs) have been evaluated using different methods in Japan and Europe. In Japan, the Hiroshima High-Precision Radiotherapy Cancer Center (HIPRAC) developed the computed tomography number calibration audit (HIPRAC-CTCA) based on a stoichiometric method, while in Europe, the European Particle Therapy Network (EPTN) implemented a method using validated tissue-equivalent inserts. Comparing these approaches is essential to improving consistency and reliability.
[PURPOSE] This study aims to enhance the reliability of the HIPRAC method by comparing it with the EPTN consensus guide-based HLUT generation methods used in multi-institutional evaluations.
[METHODS] HLUTs were generated using the HIPRAC and EPTN methods for both head and body phantom configurations. The HIPRAC-based HLUT was created by measuring CT numbers of tough lung and tough bone inserts, applying the stoichiometric method, and calculating the theoretical HLUTs for representative tissues based on the International Commission on Radiological Protection Publication 110. The EPTN-based HLUT was generated by measuring the CT numbers of validated tissue-equivalent inserts, calculating the CT numbers of human tissues using the stoichiometric method, and determining the HLUT through piecewise linear regression between CT numbers and stopping-power ratios (SPRs) for both tissue-equivalent inserts and human tissues. ΔSPR values were calculated by subtracting the EPTN-based HLUT from the HIPRAC-based HLUT and were categorized into lung, soft tissue, and bone groups. Representative brain tumor and prostate cancer cases were analyzed to evaluate spot-wise range shifts (ΔR) when applying the two HLUTs.
[RESULTS] Both methods showed good agreement in lung, soft tissue, and bone, with all ΔSPR values within ± 2% and mean differences ≤ 1%. In cortical bone, ΔSPR reached approximately 2%-3%, leading to minor range shifts. In the clinical case analysis, mean ΔR were -0.28 mm for the brain tumor case and -0.45 mm for the prostate cancer case, indicating that proton range differences between the two HLUTs were negligibly small.
[CONCLUSIONS] The established HLUT generation methods for CT-based SPR prediction developed in Japan and Europe were compared and showed good agreement across all tissue types. Range differences in clinical cases were minor, and ΔSPR variations in cortical bone corresponded to negligible proton range deviations. These findings indicate that the European and Japanese approaches are practically equivalent and support the validity and reliability of the HIPRAC-CTCA method.
[PURPOSE] This study aims to enhance the reliability of the HIPRAC method by comparing it with the EPTN consensus guide-based HLUT generation methods used in multi-institutional evaluations.
[METHODS] HLUTs were generated using the HIPRAC and EPTN methods for both head and body phantom configurations. The HIPRAC-based HLUT was created by measuring CT numbers of tough lung and tough bone inserts, applying the stoichiometric method, and calculating the theoretical HLUTs for representative tissues based on the International Commission on Radiological Protection Publication 110. The EPTN-based HLUT was generated by measuring the CT numbers of validated tissue-equivalent inserts, calculating the CT numbers of human tissues using the stoichiometric method, and determining the HLUT through piecewise linear regression between CT numbers and stopping-power ratios (SPRs) for both tissue-equivalent inserts and human tissues. ΔSPR values were calculated by subtracting the EPTN-based HLUT from the HIPRAC-based HLUT and were categorized into lung, soft tissue, and bone groups. Representative brain tumor and prostate cancer cases were analyzed to evaluate spot-wise range shifts (ΔR) when applying the two HLUTs.
[RESULTS] Both methods showed good agreement in lung, soft tissue, and bone, with all ΔSPR values within ± 2% and mean differences ≤ 1%. In cortical bone, ΔSPR reached approximately 2%-3%, leading to minor range shifts. In the clinical case analysis, mean ΔR were -0.28 mm for the brain tumor case and -0.45 mm for the prostate cancer case, indicating that proton range differences between the two HLUTs were negligibly small.
[CONCLUSIONS] The established HLUT generation methods for CT-based SPR prediction developed in Japan and Europe were compared and showed good agreement across all tissue types. Range differences in clinical cases were minor, and ΔSPR variations in cortical bone corresponded to negligible proton range deviations. These findings indicate that the European and Japanese approaches are practically equivalent and support the validity and reliability of the HIPRAC-CTCA method.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (2)
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.